BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 8536447)

  • 21. Effects of Norplant contraceptive subdermal implants on serum lipids and lipoproteins.
    Otubu JA; Towobola OA; Aisien AO; Ogunkeye OO
    Contraception; 1993 Feb; 47(2):149-59. PubMed ID: 8449015
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolic parameter, bleeding, and weight changes in U.S. women using progestin only contraceptives.
    Mainwaring R; Hales HA; Stevenson K; Hatasaka HH; Poulson AM; Jones KP; Peterson CM
    Contraception; 1995 Mar; 51(3):149-53. PubMed ID: 7621683
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism.
    Godsland IF; Crook D; Simpson R; Proudler T; Felton C; Lees B; Anyaoku V; Devenport M; Wynn V
    N Engl J Med; 1990 Nov; 323(20):1375-81. PubMed ID: 2146499
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of a low-dose estrogen-antiandrogen combination (Diane-35) on lipid and carbohydrate metabolism in patients with polycystic ovary syndrome.
    Prelević GM; Würzburger MI; Trpković D; Balint-Perić L
    Gynecol Endocrinol; 1990 Sep; 4(3):157-68. PubMed ID: 2284980
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of the subdermal contraceptive etonogestrel implant (Implanon) on biochemical and hormonal parameters (three years follow-up).
    Inal MM; Yildirim Y; Ertopcu K; Avci ME; Ozelmas I; Tinar S
    Eur J Contracept Reprod Health Care; 2008 Sep; 13(3):238-42. PubMed ID: 18609340
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A cross-over study of three oral contraceptives containing ethinyloestradiol and either desogestrel or levonorgestrel.
    Song S; Chen JK; Yang PJ; He ML; Li LM; Fan BC; Rekers H; Fotherby K
    Contraception; 1992 Jun; 45(6):523-32. PubMed ID: 1535580
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insulin sensitivity is unaltered by the use of the Norplant subdermal implant contraceptive.
    Koopersmith TB; Lobo RA
    Contraception; 1995 Mar; 51(3):197-200. PubMed ID: 7621688
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Carbohydrate and lipid studies during six months' treatment with megestrol acetate. Measurements of blood glucose, insulin, growth hormone, and triglycerides.
    Spellacy WN; Newton RE; Buhi WC; Birk SA
    Am J Obstet Gynecol; 1973 Aug; 116(8):1074-8. PubMed ID: 4721135
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuroendocrine mechanism of anovulation in users of contraceptive subdermal implant of nomegestrol acetate (Uniplant).
    Barnhart K; Devoto L; Pommer R; Sir-Pettermann T; Robinovic J; Coutinho E
    Fertil Steril; 1997 Feb; 67(2):250-5. PubMed ID: 9022598
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Subdermal contraceptive implants.
    Peralta O; Diaz S; Croxatto H
    J Steroid Biochem Mol Biol; 1995 Jun; 53(1-6):223-6. PubMed ID: 7626459
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An open-label study of subdermal implants of estradiol-only versus subdermal implants of estradiol plus nomegestrol acetate: effects on symptom control, lipid profile and tolerability.
    Barbosa IC; Coutinho EM; Oladapo L; Noronha CF; Mota RL; Lopes AC; Lopes RC
    Gynecol Endocrinol; 2009 Apr; 25(4):269-75. PubMed ID: 19408176
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparison of the effects of NORPLANT capsules and NORPLANT-2 rods on clinical chemistry: metabolic changes.
    Singh K; Viegas OA; Ratnam SS
    Ann Acad Med Singap; 1990 Nov; 19(6):833-6. PubMed ID: 2130749
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of long-term use of testosterone enanthate. II. Effects on lipids, high and low density lipoprotein cholesterol and liver function parameters.
    Tyagi A; Rajalakshmi M; Jeyaraj DA; Sharma RS; Bajaj JS
    Int J Androl; 1999 Dec; 22(6):347-55. PubMed ID: 10624603
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative metabolic effects of three types of combined oral contraceptive pills in Chinese women.
    Prasad RN; Liew D; Ratnam SS
    Contraception; 1989 Jan; 39(1):21-35. PubMed ID: 2521321
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical chemistry in women treated with levonorgestrel implants (Norplant) or a TCu 200 IUD.
    Croxatto HB; Diaz S; Robertson DN; Pavez M
    Contraception; 1983 Mar; 27(3):281-8. PubMed ID: 6406139
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of transdermal contraception on lipid profiles, carbohydrate metabolism and coagulogram in Thai women.
    Kiriwat O; Petyim S
    Gynecol Endocrinol; 2010 May; 26(5):361-5. PubMed ID: 20050766
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of Implanon on lipid metabolism in comparison with Norplant.
    Suherman SK; Affandi B; Korver T
    Contraception; 1999 Nov; 60(5):281-7. PubMed ID: 10717780
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative assessment of the effects of subdermal levonorgestrel implant system and long acting progestogen injection method on lipid metabolism.
    Anwar M; Soejono SK; Maruo T; Abdullah N
    Asia Oceania J Obstet Gynaecol; 1994 Mar; 20(1):53-8. PubMed ID: 8172528
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Two-year follow-up of changes in clinical chemistry in Singaporean Norplant acceptors: metabolic changes.
    Singh K; Viegas OA; Liew D; Singh P; Ratnam SS
    Contraception; 1989 Feb; 39(2):129-36. PubMed ID: 2495887
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Longitudinal Changes in Serum Levels of Angiopoietin-Like Protein 6 and Selenoprotein P After Gastric Bypass Surgery.
    Lim J; Park HS; Lee SK; Jang YJ; Lee YJ; Heo Y
    Obes Surg; 2016 Apr; 26(4):825-32. PubMed ID: 26231823
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.